Functional osteoclast attachment requires inositol-1,4,5-trisphosphate receptor-associated cGMP-dependent kinase substrate

Laboratory Investigation

Volumn 90, Issue 10, 2010, Pages 1533-1542

  Yaroslavskiy, Beatrice B ^a   Turkova, Irina ^a   Wang, Yujuan ^a   Robinson, Lisa J ^a   Blair, Harry C ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

endoplasmic reticulum; IP3R2; JAW1L; migfilin; osteoclast differentiation; VASP

Indexed keywords

CALCIUM ION; CALPAIN; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE 1BETA; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR 1; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR ASSOCIATED CYCLIC GMP DEPENDENT PROTEIN KINASE SUBSTRATE; NITRIC OXIDE; PHOSPHOTRANSFERASE; SERINE; SMALL INTERFERING RNA; STEROID RECEPTOR COACTIVATOR 1; UNCLASSIFIED DRUG;

ACID SECRETION; ARTICLE; BONE DEFECT; BONE MASS; BONE TURNOVER; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL ADHESION; CELL MOTILITY; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NUCLEOTIDE SEQUENCE; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

ANIMALS; BONE RESORPTION; CALCIUM; CALPAIN; CELL MOVEMENT; CELLS, CULTURED; CYCLIC GMP-DEPENDENT PROTEIN KINASES; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MEMBRANE PROTEINS; NITRIC OXIDE; OSTEOCLASTS; PHOSPHOPROTEINS; PHOSPHORYLATION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

EID: 77957265020     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.120     Document Type: Article

References (31)

1. Blair HC, Yaroslavskiy BB, Robinson LJ, et al. Osteopetrosis with microlacunar resorption because of defective integrin organization. Lab Invest 2009;89:1007-1017.
2. Yaroslavskiy BB, Sharrow AC, Wells A, et al. Necessity of inositol (1,4,5)- trisphosphate receptor 1 and m-calpain in NO-induced osteoclast motility. J Cell Sci 2007;120:2884-2894. (Pubitemid 47394262)
3. Morikawa K, Goto T, Tanimura A, et al. Distribution of inositol 1,4,5- trisphosphate receptors in rat osteoclasts. Acta Histochem Cytochem 2008;41:7-13. (Pubitemid 351679429)
4. Kuroda Y, Hisatsune C, Nakamura T, et al. Osteoblasts induce Ca2+ oscillation-independent NFATc1 activation during osteoclastogenesis. Proc Natl Acad Sci USA 2008;105:8643-8648. (Pubitemid 351987733)
5. Schlossmann J, Ammendola A, Ashman K, et al. Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ib. Nature 2000;404:197-201. (Pubitemid 30154489)
6. Fritsch RM, Saur D, Kurjak M, et al. InsP3R-associated cGMP kinase substrate (IRAG) is essential for nitric oxide-induced inhibition of calcium signaling in human colonic smooth muscle. J Biol Chem 2004;279:12551-12559. (Pubitemid 38445826)
7. Shaughnessy JD, Largaespada DA, Tian E, et al. Mrvi1, a common MRV integration site in BXH2 myeloid leukemias, encodes a protein with homology to a lymphoid-restricted membrane protein Jaw1. Oncogene 1999;18:2069-2084. (Pubitemid 29178575)
8. Ammendola A, Geiselhs?ringer A, Hofmann F, et al. Molecular determinants of the interaction between the inositol 1,4,5- trisphosphate receptor-associated cGMP kinase substrate (IRAG) and cGMP kinase Ib. J Biol Chem 2001;276:24153-24159. (Pubitemid 37410821)
9. Casteel DE, Zhang T, Zhuang S, et al. cGMP-dependent protein kinase anchoring by IRAG regulates its nuclear translocation and transcriptional activity. Cell Signal 2008;20:1392-1399.
10. Antl M, von BrYhl ML, Eiglsperger C, et al. IRAG mediates NO/cGMPdependent inhibition of platelet aggregation and thrombus formation. Blood 2007;109:552-559. (Pubitemid 46105953)
11. Murthy KS, Zhou H. Selective phosphorylation of the IP3R-I in vivo by cGMP-dependent protein kinase in smooth muscle. Am J Physiol Gastrointest Liver Physiol 2003;284:G221-G230. (Pubitemid 36120127)
12. Cui J, Matkovich SJ, deSouza N, et al. Regulation of the type 1 inositol 1,4,5-trisphosphate receptor by phosphorylation at tyrosine353. J Biol Chem 2004;279:16311-16316. (Pubitemid 38509326)
13. Lee B, Vermassen E, Yoon SY, et al. Phosphorylation of IP3R1 and the regulation of [Ca2+]i responses at fertilization: a role for the MAP kinase pathway. Development 2006;133:4355-4365.
14. Marks AR. Intracellular calcium-release channels: regulators of cell life and death. Am J Physiol 1997;272:H597-H605. (Pubitemid 27142607)
15. Yaroslavskiy BB, Zhang Y, Kalla SE, et al. NO-dependent osteoclast motility: reliance on cGMP-dependent protein kinase I and VASP. J Cell Sci 2005;118:5479-5487. (Pubitemid 43079289)
16. Yaroslavskiy BB, Li Y, Ferguson DJ, et al. Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts. J Cell Biochem 2004;91:962-972.
17. Robinson LJ, Yaroslavskiy BB, Griswold RD, et al. Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interactions of estrogen receptor-a with BCAR1 and Traf6. Exper Cell Res 2009;315:1287-1301.
18. Steinmann C, Landsverk ML, Barral JM, et al. Requirement of inositol 1,4,5-trisphosphate receptors for tumor-mediated lymphocyte apoptosis. J Biol Chem 2008;283:13506-13509.
19. Robinson LJ, Blair HC, Barnett JB, et al. Regulation of bone turnover by calcium-regulated calcium channels. Ann NY Acad Sci 2010;1192: 351-357.
20. Van Epps-Fung C, Williams JP, Cornwell TL, et al. Regulation of osteoclastic acid secretion by cGMP-dependent protein kinase. Biochem Biophys Res Commun 1994;204:565-571. (Pubitemid 2148297)
21. de Vries TJ, Mullender MG, van Duin MA, et al. The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts. Mol Cancer Res 2009;7:476-488.
22. Nakajima A, Sanjay A, Chiusaroli R, et al. Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia. J Bone Miner Res 2009;24:1162-1172.
23. Wilson LS, Elbatarny HS, Crawley SW, et al. Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions. Proc Natl Acad Sci USA 2008;105:13650-13655.
24. Casteel DE, Boss GR, Pilz RB. Identification of the interface between cGMP-dependent protein kinase Ib and its interaction partners TFII-I and IRAG reveals a common interaction motif. J Biol Chem 2005;280:38211-38218.
25. Broderick KE, Zhang T, Rangaswami H, et al. Guanosine 30,50-cyclic monophosphate (cGMP)/cGMP-dependent protein kinase induce interleukin-6 transcription in osteoblasts. Mol Endocrinol 2007;21:1148-1162. (Pubitemid 46984765)
26. Bakker AD, Silva VC, Krishnan R, et al. Tumor necrosis factor-a and interleukin-1b modulate calcium and nitric oxide signaling in mechanically stimulated osteocytes. Arthritis Rheum 2009;60:3336-3345.
27. Frei E, Huster M, Smital P, et al. Calcium-dependent and Calciumindependent inhibition of contraction by cGMP/cGKI in intestinal smooth muscle. Am J Physiol Gastrointest Liver Physiol 2009; 297:G834-G839.
28. Geiselhs?ringer A, Gaisa M, Hofmann F, et al. Distribution of IRAG and cGKI-isoforms in murine tissues. FEBS Lett 2004;575:19-22. (Pubitemid 39237675)
29. Marzia M, Chiusaroli R, Neff L, et al. Calpain is required for normal osteoclast function and is down-regulated by calcitonin. J Biol Chem 2006;281:9745-9754. (Pubitemid 43864693)
30. Dong SS, Williams JP, Jordan SE, et al. Nitric oxide regulation of cGMP production in osteoclasts. J Cell Biochem 1999;73:478-487. (Pubitemid 29256937)
31. Koller A, Schlossmann J, Ashman K, et al. Association of phospholamban with a cGMP kinase signaling complex. Biochem Biophys Res Commun 2003;300:155-160 (Pubitemid 36042944)